Mar Vista Investment Partners LLC Has $33.36 Million Holdings in Danaher Co. (NYSE:DHR)

Mar Vista Investment Partners LLC cut its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 3.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 145,322 shares of the conglomerate's stock after selling 4,511 shares during the period. Danaher makes up 2.3% of Mar Vista Investment Partners LLC's investment portfolio, making the stock its 22nd biggest holding. Mar Vista Investment Partners LLC's holdings in Danaher were worth $33,359,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in DHR. Howard Capital Management Group LLC boosted its position in shares of Danaher by 4.1% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate's stock worth $342,000 after purchasing an additional 48 shares in the last quarter. Tudor Financial Inc. acquired a new position in Danaher during the third quarter worth about $414,000. Anchor Investment Management LLC increased its holdings in Danaher by 1.3% in the third quarter. Anchor Investment Management LLC now owns 6,039 shares of the conglomerate's stock valued at $1,679,000 after buying an additional 78 shares in the last quarter. World Investment Advisors LLC lifted its position in shares of Danaher by 5.3% during the 3rd quarter. World Investment Advisors LLC now owns 12,948 shares of the conglomerate's stock valued at $3,600,000 after acquiring an additional 648 shares during the period. Finally, Arvest Bank Trust Division purchased a new stake in shares of Danaher during the 3rd quarter worth approximately $254,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

DHR has been the subject of several recent research reports. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. UBS Group cut their price objective on shares of Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Royal Bank of Canada restated an "outperform" rating and issued a $250.00 price objective on shares of Danaher in a report on Wednesday, April 23rd. Stifel Nicolaus raised Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective on the stock in a research report on Friday, March 14th. Finally, Guggenheim reaffirmed a "buy" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and an average price target of $264.40.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the firm's stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 11.10% of the company's stock.

Danaher Price Performance

DHR stock traded down $2.62 during trading on Monday, hitting $194.52. The company had a trading volume of 1,046,140 shares, compared to its average volume of 3,345,996. The firm has a market capitalization of $139.21 billion, a price-to-earnings ratio of 36.82, a P/E/G ratio of 2.66 and a beta of 0.86. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The business has a 50 day moving average of $200.87 and a 200 day moving average of $223.98. Danaher Co. has a fifty-two week low of $171.00 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. As a group, research analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 25th. Stockholders of record on Friday, March 28th were issued a $0.32 dividend. This is a positive change from Danaher's previous quarterly dividend of $0.27. The ex-dividend date of this dividend was Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.66%. Danaher's dividend payout ratio is 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.